CORD-19:932bcdd2f6c6d487386e8bf983e4874387771be1 / 108539-108692 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"T1666","span":{"begin":0,"end":83},"obj":"Sentence"},{"id":"T25874","span":{"begin":84,"end":153},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"We found no association between CD14-260 C-T polymorphism and susceptibility to MS. CD14 is upregulated in MS lesions, most prominently in acute lesions."}

{"project":"Epistemic_Statements","denotations":[{"id":"T243","span":{"begin":0,"end":153},"obj":"Epistemic_statement"}],"text":"We found no association between CD14-260 C-T polymorphism and susceptibility to MS. CD14 is upregulated in MS lesions, most prominently in acute lesions."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T117","span":{"begin":0,"end":83},"obj":"Sentence"},{"id":"T118","span":{"begin":84,"end":153},"obj":"Sentence"}],"text":"We found no association between CD14-260 C-T polymorphism and susceptibility to MS. CD14 is upregulated in MS lesions, most prominently in acute lesions."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T545","span":{"begin":80,"end":82},"obj":"Disease"},{"id":"T546","span":{"begin":107,"end":109},"obj":"Disease"},{"id":"T50296","span":{"begin":80,"end":82},"obj":"Disease"},{"id":"T42802","span":{"begin":107,"end":109},"obj":"Disease"}],"attributes":[{"id":"A545","pred":"mondo_id","subj":"T545","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A546","pred":"mondo_id","subj":"T546","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A58433","pred":"mondo_id","subj":"T50296","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A28198","pred":"mondo_id","subj":"T42802","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"}],"text":"We found no association between CD14-260 C-T polymorphism and susceptibility to MS. CD14 is upregulated in MS lesions, most prominently in acute lesions."}